Furthermore, obesity and adipogenesis are linked to alterations in various signaling pathways within the WAT, with 5’-adenosine monophosphate (AMP)-activated protein kinase (AMPK) emerging as a pivotal regulator due to its anti-adipogenic effects across multiple tissues, including the liver and skeletal muscle [16,17]. This evidence concerns the gene PRKAA2 and obesity disorder.